BackBioNTech SE Overview
BioNTech SE - ADR

BioNTech SE Target Price

Analysts' 12-month price predictions for BNTX.

Share Price

$112.49

Average Target Price

$126.8012.7% upside

5 analysts in the last 4 months

High: $145 | Low: $110

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2025-07-10Morgan StanleyTerence Flynn$13318.2% upsideOpen
2025-06-02Leerink PartnersDaina Graybosch$1120.4% downsideOpen
2025-05-29Goldman SachsAsad Haider$1102.2% downsideOpen
2025-05-14H.C. WainwrightRobert Burns$13419.1% upsideOpen
2025-04-01H.C. Wainwright$14528.9% upsideOpen
2024-11-19Evercore ISICory Kasimov$12511.1% upsideOpen
2024-11-13Leerink PartnersDaina Graybosch$1217.6% upsideOpen
2024-11-08Goldman SachsChris Shibutani$13721.8% upsideOpen
2024-11-04BMO CapitalEtzer Darout$12612% upsideOpen
2024-09-23Morgan StanleyTerence Flynn$14528.9% upsideOpen
2024-09-17JefferiesAkash Tewari$15033.3% upsideOpen
2024-09-16Bank of America SecuritiesTazeen Ahmad$15033.3% upsideOpen
2024-09-13JefferiesAkash Tewari$9614.7% downsideOpen
2024-08-06Deutsche BankEmmanuel Papadakis$9515.5% downsideOpen
2024-08-05Morgan StanleyTerence Flynn$9317.3% downsideOpen
2024-08-02HSBCYifeng Liu$10110.2% downsideOpen
2024-06-26H.C. WainwrightRaghuram Selvaraju$1130.5% upsideOpen
2024-05-13Evercore ISICory Kasimov$10011.1% downsideOpen
2024-05-07BMO CapitalEtzer Darout$1228.5% upsideOpen
2024-03-22HSBCYifeng Liu$9020% downsideOpen
2024-03-21Canaccord GenuityWilliam Maughan$17152% upsideOpen
2024-03-21BMO CapitalEtzer Darout$1239.3% upsideOpen
2024-03-21Goldman SachsChris Shibutani$9119.1% downsideOpen
2023-01-31Goldman Sachs$15638.7% upsideOpen
2022-12-02Leerink PartnersMani Foroohar$8128% downsideOpen
2022-05-17UBSAndrew Ang$16849.3% upsideOpen
2022-05-10Morgan StanleyMatthew Harrison$19573.3% upsideOpen
2022-04-16H.C. WainwrightRobert Burns$298164.9% upsideOpen
2022-04-10Canaccord GenuityArlinda Lee$300166.7% upsideOpen
2022-01-21UBSEliana Merle$17051.1% upsideOpen
2021-12-22Kempen & CoSuzanne van Voorthuizen$350211.1% upsideOpen
2021-12-09Leerink PartnersDaina Graybosch$253124.9% upsideOpen
2021-10-04Bryan Garnier & Co LtdOlga Smolentseva$359219.1% upsideOpen